Pneumococcal conjugate vaccination at birth in a high-risk setting: No evidence for neonatal T-cell tolerance

Concerns about the risk of inducing immune deviation-associated “neonatal tolerance” as described in mice have restricted the widespread adoption of neonatal vaccination. The aim of this study was to demonstrate the immunological feasibility of neonatal pneumococcal conjugate vaccination (PCV) which...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Biggelaar, Anita H.J., Pomat, William, Bosco, Anthony, Phuanukoonnon, Suparat, Devitt, Catherine J., Nadal-Sims, Marie A., Siba, Peter M., Richmond, Peter C., Lehmann, Deborah, Holt, Patrick G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146700/
https://www.ncbi.nlm.nih.gov/pubmed/21645573
http://dx.doi.org/10.1016/j.vaccine.2011.05.065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146700/
https://www.ncbi.nlm.nih.gov/pubmed/21645573
http://dx.doi.org/10.1016/j.vaccine.2011.05.065

Ejemplares similares